Search PubMed⌕ Search

Biomedical subjects

T A Douglas

Publications and source records attributed to T A Douglas.

At least 19 recordsLinked to original sources
PubMed2001

Maternal awareness of sudden infant death syndrome in North Queensland, Australia: an analysis of infant care practices.

OBJECTIVES: To assess awareness of sudden infant death syndrome (SIDS) and risk reducing recommendations in a sample of mothers in North Queensland, Australia, and to examine their infant care practices. METHOD: Interviews conducted with 195 women using a standardized questionnaire between October 1997 and January 1998. RESULTS: 191 questionnaires analyzed; 134 (70.2%) Caucasian and 57 (29.8%) indigenous women. Four women with previous SIDS experience were excluded from the analysis. Eight (4.2%) had never heard of SIDS. Twenty-nine (15.2%) had heard of SIDS and 154 (80.6%) had heard of SIDS and could list risk recommendations to reduce its incidence. Multivariate analysis identified ethnicity as the only significant predictor of maternal knowledge. Indigenous mothers knew less about SIDS: adjusted odds ratio (OR) = 5.4; 95% confidence interval (CI) = [2.1-14.0]. Avoidance of prone sleeping was the most frequently identified recommendation (n = 132), with no smoking in pregnancy (n = 48) and breastfeeding (n = 40) identified least frequently. There were 80.2% of mothers who put their infant in non-prone positions to sleep. Only 48 (25%) women identified smoking in pregnancy, and 93 (48.6%) smoking in the infant's environment as risk factors. Indigenous women were more likely to smoke in their pregnancy (P = 0.004), bed share with their infant (P = 0.0001), and have smokers in the home. CONCLUSION: There is a high level of awareness of SIDS and the main associated risk factor of infant prone sleeping, but the link between SIDS and smoking requires further emphasis. Future campaigns should ensure the SIDS message is delivered more effectively to the indigenous communities.

Adult↗
PubMed1989

Acute phase response in calves following infection with Pasteurella haemolytica, Ostertagia ostertagi and endotoxin administration.

The concentrations of bovine acute phase proteins were monitored in plasma following experimental infection with Pasteurella haemolytica and Ostertagia ostertagi and after endotoxin administration. Raised levels of haptoglobin, alpha 1 proteinase inhibitor and seromucoid were detected after pasteurella infection and endotoxin administration. Ceruloplasmin levels increased after endotoxin administration but not during pasteurella infection. Raised levels of the four acute phase proteins were found in eight of 19 calves infected with ostertagia but showed a variable pattern and did not correlate with plasma pepsinogen increases. Bovine alpha 1 antichymotrypsin and alpha 2 macroglobulin were identified as acute phase reactants.

Acute-Phase Proteins↗
PubMed1989

Insemination of beagle bitches with frozen semen.

Behaviour, vaginal cytology and plasma progesterone concentrations were monitored during oestrus in a group of 6 beagle bitches before intrauterine insemination with frozen semen. At intervals after insemination, the reproductive tracts were examined for evidence of conception, which occurred in 5 of the bitches. One pregnant bitch had received treatment with stilboestrol before insemination.

Animals↗
PubMed1988

Bovine acute phase response following turpentine injection.

The serum levels of five proteins, alpha 1 antitrypsin, ceruloplasmin, fibrinogen, haptoglobin and seromucoid, were measured daily in calves after the subcutaneous injection of oil of turpentine. Raised concentrations were detected on the second and third days after injection with peak levels occurring on the fourth to seventh days and returning to normal by the 17th day. Levels of four of these proteins, alpha 1 antitrypsin, ceruloplasmin, haptoglobin and seromucoid were compared in the same calves following three different doses of turpentine. Levels of haptoglobin and seromucoid varied with the dose whereas ceruloplasmin and alpha 1 antitrypsin levels did not.

Acute-Phase Proteins↗
PubMed1988

Inhibition of elastase by canine serum: demonstration of an acute phase response.

Canine serum alpha 1-proteinase inhibitor is not a major acute phase reactant in the dog, unlike the equivalent protein in humans. The possibility that an alternative protease inhibitor system is stimulated during the acute phase response in the dog was investigated. alpha 2-macroglobulin was not an acute phase reactant, but an inhibitor of elastase was identified in canine serum which could be separated from proteinase inhibitor by gel filtration and which was shown to be an acute phase reactant. This protein has been named canine elastase inhibitor.

Acute-Phase Proteins↗
PubMed1988

Acute phase response in the dog following surgical trauma.

The levels of five acute phase reactants and serum glycoproteins were measured in dogs following surgical trauma. Canine C-reactive protein peaked 24 hours after surgery and peak levels of ceruloplasmin, haptoglobin and seromucoid were detected on the fourth to sixth days. Levels of serum glycoproteins varied in a similar manner to ceruloplasmin, haptoglobin and seromucoid. There was very little variation in the levels of alpha 1 antitrypsin.

Acute-Phase Proteins↗
PubMed1987

Control of breeding in the mare.

Six mares were studied over a period of two years under varying conditions of lighting from total darkness to normal ambient lighting. The mares continued to cycle during the winter under natural lighting and also when kept in total darkness. Circulating melatonin, progesterone and oestrogen concentrations were determined and related to clinical changes in the reproductive tract.

Anestrus↗
PubMed1987

Plasma prolactin concentrations in non-pregnant mares at different times of the year and in relation to events in the cycle.

Plasma prolactin concentrations were measured in mares using an homologous radioimmunoassay. An annual rhythm in plasma prolactin was found, with concentrations higher during the summer than during the winter. In addition to this seasonal pattern, occasional high concentrations of prolactin were seen when concentrations were otherwise basal. Blood samples taken from mares during an oestrous cycle in October-November showed that prolactin values were basal for most of the cycle, with a marked rise in prolactin shortly before the onset of oestrus. This prolactin peak was associated with an increase in the size of the largest follicle, and with a peak of PGFM in some mares, but did not appear to be related to the LH surge. In oestrous cycles in March and May-June, there was a wide variation in the baseline of prolactin secretion, in accordance with the seasonal pattern already mentioned. However, the peak of prolactin seen around oestrus in October-November was less obvious in March and May-June. Post-partum mares showed a high but irregular profile of prolactin concentrations with no clear-cut pattern in relation to the oestrous cycle.

Animals↗
PubMed1986

The effect of neuraminidase on the molecular weight and the isoelectric point of the steroid induced alkaline phosphatase of dogs.

Isoelectric focusing and gradient polyacrylamide gel electrophoresis were used to define the physical differences between canine liver alkaline phosphatase (LAP) and steroid induced alkaline phosphatase (SIAP). LAP has an isoelectric point (pI) of pH 4.3 and a molecular radius (Mr) of 100,000, while SIAP has a pI of pH 3.5 and an Mr of 110,000. After removal of sialic acid residues by neuraminidase, the two isoenzymes were still distinct. The pIs of both LAP and SIAP were increased with the pI of LAP becoming pH 4.7 to 4.8 and that of SIAP becoming pH 4.5 to 4.6. On gradient polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate, SIAP gave a single band of Mr 100 000 after neuraminidase treatment, while LAP increased in molecular size in spite of the denaturing conditions of the electrophoretic separation.

Alkaline Phosphatase↗
PubMed1986

Plasma prolactin concentrations and cyclic activity in pony mares during parturition and early lactation.

Five pony mares were blood sampled during late pregnancy, foaling and early lactation. An homologous assay for horse prolactin was used to measure plasma prolactin concentrations in these samples. Regular estimates of cyclic activity were also made. Plasma prolactin concentrations rose markedly in the last week of pregnancy and remained high although variable in early lactation, before declining to basal levels by 1-2 months post partum. All mares showed a post-partum oestrus 7.0 +/- 0.9 days after parturition. One mare whose foal died shortly after birth showed a rapid decline in plasma prolactin values after death of the foal and an early oestrous period (4 days after parturition). The pattern of prolactin changes reported for the mare are in agreement with those reported for other mammalian species.

Animals↗
PubMed1986

Acute phase response and mastitis in the cow.

The levels of three plasma proteins, which are classed as acute phase reactants, were compared in a group of cows which suffered from mastitis with those in a group of cows which were clinically normal. The plasma levels of haptoglobin, ceruloplasmin and alpha 1 antitrypsin were higher in the cows with mastitis than in normal cows.

Animals↗
PubMed1983

Studies on a new paste preparation of phenylbutazone.

The absorption characteristics of a new paste preparation of phenylbutazone were studied in ponies and thoroughbreds. The results suggested that at a similar dose rate of 5 mg/kg greater bioavailability results from the paste than from a powder preparation. Delivery of an accurate dosage of the paste was not possible using the multidose applicator. Repeated administration of the paste preparation (5 mg/kg twice daily) indicated that it is more toxic to both ponies and thoroughbreds than a powder preparation. In addition to the toxic manifestations previously reported, a neutropenia developed during administration. Repeated intravenous administration of phenylbutazone (3.3 mg/kg twice daily) for eight days produced no adverse effects.

Absorption↗
PubMed1981

Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study.

Toxic effects of phenylbutazone (PBZ) in ponies and horses were studied, using a variety of biochemical, pathophysiologic, and pathologic methods. At dosage levels of 10 to 12 mg/kg of body weight/day for 8 to 10 days, ponies frequently developed clinical signs of toxicosis characterized by hypoproteinemia. Studies using 51CrCl3 demonstrated that PBZ caused a protein-losing gastroenteropathy. The plasma loss was usually associated with gastrointestinal ulceration, but sometimes occurred without obvious lesions in mildly affected animals. Similar studies (8.2 mg/kg/day for 13 days) in Thoroughbreds indicated that they were less susceptible to PBZ toxicity; however, a degree of hypoproteinemia occurred in 4 of 6 treated Thoroughbreds.

Animals↗